What Is Pinealon?
Pinealon research has attracted significant interest in neuropeptide biology and longevity science, with this short tripeptide demonstrating targeted regulatory effects on neuronal tissue, circadian biology, and antioxidant defense mechanisms in preclinical models.
Pinealon (Glu-Asp-Arg, molecular weight approximately 417.4 Da) is a synthetic tripeptide bioregulator developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson and colleagues — the same research group responsible for Epitalon (the telomerase-activating tetrapeptide), Thymalin (the thymic bioregulator), and Cartalax (the cartilage bioregulator). Pinealon was developed within the framework of peptide bioregulator theory, which proposes that short peptides derived from specific tissues act as tissue-specific gene expression regulators through direct interaction with chromatin and transcription factor networks. Pinealon was identified as the active peptide fraction from pineal gland extract, with research focus on its role as a neural tissue bioregulator — particularly in the context of neuroprotection, circadian rhythm support, and age-related neurological decline.
Mechanism of Action
Neuroprotective Gene Expression Regulation
In alignment with peptide bioregulator theory, Pinealon is hypothesized to interact directly with DNA and chromatin structures in neuronal cells — modulating the expression of genes involved in neuronal survival, DNA repair, and stress response. Research has demonstrated that short peptide bioregulators can penetrate cell nuclei and interact with chromatin in a sequence-specific manner, influencing transcription factor binding and gene expression patterns. In neural tissue specifically, Pinealon has been studied for its ability to normalize gene expression profiles in aged neurons toward more youthful patterns.
Antioxidant Defense Enhancement
Neural tissue is exceptionally vulnerable to oxidative damage due to its high metabolic rate, abundant polyunsaturated fatty acids, and relatively limited antioxidant defenses compared to other tissues. Research has examined Pinealon’s ability to upregulate endogenous antioxidant enzyme activity — including superoxide dismutase and catalase — in neuronal cells under oxidative stress conditions. Reduction of lipid peroxidation markers and DNA oxidation products following Pinealon treatment has been documented in preclinical models of oxidative stress.
Circadian Pathway Modulation
As a peptide derived from pineal gland tissue — the master circadian organ — Pinealon has documented interactions with melatonin synthesis and secretion pathways. Research has investigated its ability to influence the activity of arylalkylamine N-acetyltransferase (AANAT), the rate-limiting enzyme in melatonin biosynthesis, and to modulate expression of core circadian clock genes including CLOCK, BMAL1, and PER family members. Disruption of circadian rhythms is a well-established feature of neurological aging and neurodegenerative disease, making circadian pathway support a relevant research outcome.
Neuronal DNA Repair Promotion
Age-related accumulation of DNA damage in post-mitotic neurons is a primary driver of neurological decline and neurodegenerative pathology. Research has examined Pinealon’s effects on DNA repair pathway activity in neuronal cells, including base excision repair and nucleotide excision repair mechanisms. Its proposed chromatin-interacting mechanism positions it as a potential modulator of the transcriptional machinery that coordinates DNA damage recognition and repair in neural tissue.
Research Applications
Age-Related Neurological Decline Research
The primary research application for Pinealon concerns age-related neurological decline — a multi-factorial process involving accumulated oxidative damage, mitochondrial dysfunction, chronic neuroinflammation, and progressive synaptic loss. Research has examined Pinealon’s ability to modulate multiple drivers of neurological aging simultaneously through its proposed gene expression regulatory mechanism, investigating outcomes including neuronal viability, cognitive performance metrics, and neuroinflammatory markers in aged animal models.
Circadian Biology and Sleep Research
Circadian rhythm disruption is one of the most consistent features of neurological aging — manifesting as reduced melatonin secretion amplitude, phase-shifted sleep-wake cycles, and dysregulation of circadian gene expression across multiple tissues. Pinealon’s documented interactions with pineal gland function and melatonin synthesis pathways make it a relevant research tool for studying circadian rhythm restoration in aged animal models and for investigating the relationship between circadian health and neurological aging outcomes.
Neuroprotection Research
Research has examined Pinealon in models of acute neurological injury — including ischemia-reperfusion, excitotoxicity, and oxidative stress — investigating whether its antioxidant and gene expression regulatory properties translate into measurable neuroprotective effects in injury contexts. Its small size and proposed cell-penetrating properties make it a practical research tool for investigating nuclear-level neuroprotective mechanisms in vitro and in vivo.
Neurodegenerative Disease Models
The combination of neuroprotective, antioxidant, and circadian-supporting mechanisms makes Pinealon relevant to neurodegenerative disease research, particularly for conditions where oxidative stress, circadian disruption, and neuronal DNA damage play documented roles. Research has examined its effects in models relevant to Alzheimer’s disease, Parkinson’s disease, and age-related macular degeneration — conditions where pineal gland dysfunction and melatonin pathway disruption are well-documented features.
Pinealon in the AminoForge Longevity and Cognitive Research Catalog
Pinealon is most frequently studied alongside compounds targeting complementary longevity and neuroprotective mechanisms. At AminoForge, researchers investigating neurological aging may find it productive to study Pinealon alongside Epitalon — which shares its bioregulator origin and targets telomere biology and pineal function through a distinct mechanism — and Dihexa, which promotes neurogenesis and synaptogenesis through HGF/MET pathway potentiation. For researchers investigating the broader bioregulator class, Cartalax (connective tissue bioregulator) and Thymalin (thymic bioregulator) offer tissue-specific regulatory mechanisms in non-neural tissues. For further reading see: Pinealon neuroprotective mechanisms in preclinical research (PubMed).
Shop Pinealon at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
Pinealon is available as a lyophilized powder. With a molecular weight of approximately 417.4 Da, it is one of the smallest research peptides available and is relatively stable compared to larger compounds. Standard storage at −20°C for lyophilized powder applies, with reconstituted solutions stored at 2–8°C protected from light. Bacteriostatic water is the standard reconstitution vehicle. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the 417.4 Da molecular weight and correct Glu-Asp-Arg sequence.
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.